You have 9 free searches left this month | for more free features.

15-088

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Healthy Volunteers Trial in Gières, Marseille (IFB-088 (2.5-60.0mg) oral capsule, Placebo (2.5-60.mg) oral capsule, IFB-088

Completed
  • Healthy Volunteers
  • IFB-088 (2.5-60.0mg) oral capsule
  • +3 more
  • Gières, France
  • +1 more
Nov 18, 2021

Lyme Disease Trial in Worldwide (VLA15, Saline)

Not yet recruiting
  • Lyme Disease
  • VLA15
  • Saline
  • New London, Connecticut
  • +25 more
Aug 2, 2022

Rheumatoid Arthritis Trial in Worldwide (AMG 827)

Terminated
  • Rheumatoid Arthritis
  • AMG 827
  • Scottsdale, Arizona
  • +43 more
Feb 3, 2022

Psoriasis, Plaque Psoriasis Trial in Worldwide (EDP1815, Placebo)

Completed
  • Psoriasis
  • Plaque Psoriasis
  • Santa Rosa, California
  • +28 more
Jan 6, 2022

Osteoarthritis of the Knee Trial in Austria, Poland, Spain (Matching Placebo, GRT6005)

Completed
  • Osteoarthritis of the Knee
  • Linz, Austria
  • +25 more
Jul 13, 2021

SLE Trial in Worldwide (ESK-001, Placebo)

Recruiting
  • SLE
  • Anniston, Alabama
  • +138 more
Jul 21, 2023

Postmenopausal Osteoporosis Trial in Worldwide (FKS518, US-licensed Prolia)

Active, not recruiting
  • Postmenopausal Osteoporosis
  • Sofia, Sofia City, Bulgaria
  • +75 more
Aug 29, 2022

Metastatic Castration-resistant Prostate Cancer Trial in Beijing (1.1 GBq (30 mCi) of 177Lu-P17-087, 1.1 GBq (30 mCi) of

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • 1.1 GBq (30 mCi) of 177Lu-P17-087
  • 1.1 GBq (30 mCi) of 177Lu-P17-088
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Oct 30, 2022

Eczema, Atopic Dermatitis Trial in Worldwide (KY1005, Placebo)

Active, not recruiting
  • Eczema
  • Atopic Dermatitis
  • Fremont, California
  • +102 more
Dec 13, 2022

Nasal Polyps, Chronic Rhinosinusitis Trial in Worldwide (Omalizumab, Placebo)

Completed
  • Nasal Polyps
  • Chronic Rhinosinusitis
  • Birmingham, Alabama
  • +78 more
Mar 31, 2022

Hypertension Trial in Worldwide (Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg, telmisartan 40 mg/amlodipine 5

Recruiting
  • Hypertension
  • Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg
  • +7 more
  • Phoenix, Arizona
  • +84 more
Aug 19, 2022

Eosinophilic Esophagitis Trial in Worldwide (CC-93538)

Recruiting
  • Eosinophilic Esophagitis
  • Birmingham, Alabama
  • +300 more
Aug 17, 2022

Diabetes, Type 2 Trial in Worldwide (NNC0480-0389, Semaglutide, Placebo (NNC080-0389))

Recruiting
  • Diabetes Mellitus, Type 2
  • Buena Park, California
  • +95 more
Mar 31, 2022

Overweight, Overweight and Obesity, Overweight or Obesity Trial in New York (Counseling, Text Messages, Phone calls)

Recruiting
  • Overweight
  • +4 more
  • Counseling
  • +3 more
  • New York, New York
    Mexican Consulate's Ventanilla de Salud (VDS)
Mar 20, 2023

Pain Trial in Heerlen (Virtual reality intervention performed through the Oculuc Go VR glasses)

Recruiting
  • Pain
  • Virtual reality intervention performed through the Oculuc Go VR glasses
  • Heerlen, Netherlands
    Zuyderaland MC
Feb 22, 2023

NSCLC Trial in Netherlands (Durvalumab, low-dose PCI)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Almelo, Netherlands
  • +11 more
Feb 1, 2022

Amyotrophic Lateral Sclerosis, ALS Trial in France, Italy (IFB-088 50mg/day, Placebo, Riluzole 100mg/day)

Not yet recruiting
  • Amyotrophic Lateral Sclerosis
  • ALS
  • IFB-088 50mg/day
  • +2 more
  • Angers, France
  • +19 more
Aug 18, 2022

Psoriatic Arthritis Trial in Worldwide (Apremilast 20mg, Apremilast 30mg, Placebo)

Completed
  • Psoriatic Arthritis
  • Apremilast 20mg
  • +2 more
  • Phoenix, Arizona
  • +117 more
May 26, 2022

Multiple Myeloma Trial (Vorinostat, bortezomib, to vorinostat)

Completed
  • Multiple Myeloma
  • (no location specified)
Apr 29, 2021

Asthma Trial in Worldwide (FF/VI via ELLIPTA DPI, FF via ELLIPTA DPI)

Completed
  • Asthma
  • FF/VI via ELLIPTA DPI
  • FF via ELLIPTA DPI
  • Hoover, Alabama
  • +183 more
Sep 12, 2022

B-cell Non Hodgkin Lymphoma Trial in Hanzhou (CB dualCAR-NK19/70)

Not yet recruiting
  • B-cell Non Hodgkin Lymphoma
  • CB dualCAR-NK19/70
  • Hanzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Dec 25, 2022

Analgesia Trial in Erzurum (Group Suprainguinal fascia iliaca block, Group Periarticular Infiltration)

Recruiting
  • Analgesia
  • Group Suprainguinal fascia iliaca block
  • Group Periarticular Infiltration
  • Erzurum, Turkey
    Ali Ahiskalioglu
Nov 23, 2022

Osteoarthritis Trial in Worldwide (biological, drug, other)

Terminated
  • Osteoarthritis
  • tanezumab
  • +2 more
  • Graz, Austria
  • +76 more
Feb 8, 2021

aScope Single Use ERCP Study- ASSURE Study

Not yet recruiting
  • ERCP
  • +2 more
  • Endoscopic retrograde Cholangio-pancreatography (ERCP) with aScope (Single use duodenoscope
  • Nottingham, United Kingdom
    Nottingham University Hospitals NHS Trust
Feb 4, 2022